- Poster presentation
- Open Access
The toll-like receptor 4 agonist MRP8/14 protein complex (calprotectin) in autoinflammation: potential biomarker in chronic nonbacterial osteomyelitis – a case report
- Juergen Brunner1
© Brunner; licensee BioMed Central Ltd. 2014
- Published: 17 September 2014
- Serum Concentration
- Erythrocyte Sedimentation Rate
- Protein Complex
- S100 Protein
The cytoplasmic S100 proteins derived from cells of myeloid origin. Calprotectin (MRP8/14 protein complex) might be a biomarker either for autoinflammation and autoimmunopathy. Since autoinflammatory diseases might be a diagnostic challenge calprotectin may be helpful in the diagnosis of autoinflammatory diseases. Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory, noninfectious disease. CNO describes a wide spectrum from a monofocal bone lesion to the chronic recurring multifocal osteomyelitis (CRMO). Laboratory and histopathological findings are nonspecific. In some patients systemic inflammatory signs such as elevated acute phase proteins cannot be found.
To test the ability of Calprotectin (MRP8/14 protein complex) serum concentrations to monitor disease activity in patients with CNO.
Serum concentrations of Calprotectin (MRP8/14 protein complex) in a patient with CNO were determined by a sandwich ELISA.
Calprotectin (MRP8/14) level were raised heralding active disease when acute phase proteins (CrP, erythrocyte sedimentation rate). The calprotectin level was 7872,7 ng/ml (normal range 0-3000 ng/ml).
Calprotectin (MRP8/14) serum concentrations correlate closely with disease activity and may herald a flare before clinical manifestation. Therefore MRP8/14 serum concentrations are a biomarker indicating disease activity in CNO patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.